RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC).
Shi Y, Wu L, Yu X, Xing P, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y.
Shi Y, et al. Among authors: wu l.
Ann Oncol. 2020 Dec;31 Suppl 7:S1428. doi: 10.1016/j.annonc.2020.10.517. Epub 2020 Dec 13.
Ann Oncol. 2020.
PMID: 33517977
Free article.
Retracted.